ASSOCIATION OF MEDICATION PERSISTENCE AND HEALTH-CARE UTILIZATION IN HIGH-COST PATIENTS WITH MAJOR DEPRESSIVE DISORDER TREATED WITH DULOXETINE OR VENLAFAXINE XR

被引：0

作者：

Liu, X. ^{[1
]}

Tepper, P. ^{[2
]}

Mullins, C. D. ^{[3
]}

Faries, D. ^{[1
]}

Johnstone, B. ^{[1
]}

机构：

[1] Eli Lilly & Co, Indianapolis, IN 46285 USA

[2] Univ Pittsburgh, Pittsburgh, PA USA

[3] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA

来源：

VALUE IN HEALTH | 2010年 / 13卷 / 07期

关键词：

D O I：

10.1016/S1098-3015(11)73326-5

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A555 / A555

页数：1

共 37 条

[1] Cost effectiveness of duloxetine compared with venlafaxine-XR in the treatment of major depressive disorder
Van Baardewijk, M
Vis, PM
Einarson, T
[J]. VALUE IN HEALTH, 2005, 8 (06) : A209 - A210
[2] Cost effectiveness of duloxetine compared with venlafaxine-XR in the treatment of major depressive disorder
van Baardewijk, M
Vis, PMJ
Einarson, TR
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (08) : 1271 - 1279
[3] MEDICATION ADHERENCE AND HEALTH CARE COSTS AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDER TREATED WITH DULOXETINE
Zhao, Y.
Cui, Z.
Fang, Y.
Faries, D.
[J]. VALUE IN HEALTH, 2011, 14 (03) : A190 - A190
[4] Cost-effectiveness of duloxetine vs. venlafaxine XR and SSRIS in patients with major depressive disorder in primary and secondary care in Spain
De Cock, E.
Benedict, A.
Le, T. K.
Sacristin del Castillo, J. A.
Dilla, T.
[J]. VALUE IN HEALTH, 2007, 10 (06) : A295 - A296
[5] TREATMENT PERSISTENCE WITH DULOXETINE AND HEALTH CARE COSTS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER
Liu, X.
Tepper, P.
Mullins, C. D.
[J]. VALUE IN HEALTH, 2010, 13 (03) : A112 - A113
[6] ADHERENCE AND PERSISTENCE WITH DULOXETINE VERSUS ESCITALOPRAM AMONG HIGH HEALTH-CARE RESOURCES UTILIZERS WITH MAJOR DEPRESSIVE DISORDER
Tepper, P.
Liu, X.
Able, S. L.
Johnstone, B.
[J]. VALUE IN HEALTH, 2010, 13 (07) : A555 - A555
[7] Adherence and persistence with duloxetine and hospital utilization in patients with major depressive disorder
Liu, Xianchen
Tepper, Ping G.
Able, Stephen L.
[J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2011, 26 (03) : 173 - 180
[8] A COST-UTILTY ANALYSIS OF VENLAFAXINE XR COMPARED WITH DULOXETINE AND SSRIS FOR THE TREATMENT OF MAJOR DEPRESSIVE DISORDER IN ITALY
Graham, C.
Narula, H.
Liu, L. Z.
Keohane, D.
Di Virgilio, R.
[J]. EUROPEAN PSYCHIATRY, 2014, 29
[9] Treatment adherence and persistence with duloxetine, venlafaxine XR, and escitalopram among patients with major depressive disorder and chronic pain-related diseases
Wang, Junling
Liu, Xianchen
Mullins, C. Daniel
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (07) : 1303 - 1313
[10] TRAJECTORY ANALYSIS OF HEALTH CARE COSTS FOR PATIENTS WITH MAJOR DEPRESSIVE DISORDER TREATED WITH HIGH DOSES OF DULOXETINE
Cui, Z.
Faries, D.
Zhao, Y.
Niu, L.
Novick, D.
Liu, X.
[J]. VALUE IN HEALTH, 2011, 14 (03) : A191 - A191

← 1 2 3 4 →